Search this site

Explore neurofibromatosis with The Neurosurgical Case Room (TNCR), including NF1, NF2 and schwannomatosis, associated tumors, clinical features, diagnosis and neurosurgical management. Neurofibromatosis Type 1, Type 2, and Schwannomatosis Q. What is Neurofibromatosis? Neurofibromatosis refers to a group of autosomal dominant neurocutaneous disorders characterized by the formation of nerve sheath tumors, skin pigmentation abnormalities, and systemic manifestations involving multiple organ systems. The three major recognized forms are Neurofibromatosis Type 1 (NF1), Neurofibromatosis Type 2 (NF2), and Schwannomatosis, all part of the neurofibromatosis-schwannomatosis spectrum. Neurofibromatosis Type 1 (NF1) Q. What is the genetic basis of NF1? NF1 results from mutations in the NF1 gene on chromosome 17q11.2, which encodes neurofibromin, a tumor suppressor protein that negatively regulates RAS signaling. Loss of neurofibromin leads to excessive RAS/MAPK pathway activation and uncontrolled Schwann cell proliferation. Q. What is the inheritance pattern? NF1 is autosomal dominant with variable expressivity and complete penetrance by adulthood. Around 50% of cases arise from de novo mutations. Q. What are the updated 2021 International Diagnostic Criteria for Neurofibromatosis Type 1 (NF1)? Diagnosis requires two or more of the following: 1. Six or more café-au-lait macules (>5 mm prepubertal, >15 mm postpubertal). 2. Two or more neurofibromas of any type, or one plexiform neurofibroma. 3. Axillary or inguinal freckling (Crowe sign). 4. Optic pathway glioma. 5. Two or more Lisch nodules (iris hamartomas), OR two or more choroidal abnormalities (bright patch lesions identified by near-infrared reflectance imaging / optical coherence tomography). 6. Distinctive osseous lesion such as sphenoid wing dysplasia, anterolateral bowing of the tibia, or pseudarthrosis of a long bone. 7. A heterozygous pathogenic NF1 gene variant with a variant allele fraction of 50% in normal tissue. 8. A parent who meets the diagnostic criteria for NF1 specified above. (Only a biological parent who officially meets the diagnostic criteria qualifies as a positive family history. Siblings and children no longer satisfy this criterion on their own, even if they have confirmed cases of NF1.) Q. What are the additional supportive (nonessential) features of NF1? Macrocephaly, short stature, and learning disabilities or ADHD. Seizures, developmental delay, or autism spectrum traits. Scoliosis, vertebral scalloping, long bone bowing, and tibial dysplasia. Vascular lesions (e.g., renal artery stenosis, moyamoya-like disease). Endocrine abnormalities, including precocious puberty (optic-hypothalamic glioma). Pheochromocytoma, GISTs, glomus tumors, and juvenile xanthogranulomas. Choroidal hamartomas visible on near-infrared OCT. Elephantiasis neuromatosa from plexiform neurofibroma overgrowth. Q. What are the clinical features of NF1? Cutaneous: café-au-lait macules, axillary/inguinal freckles, dermal and plexiform neurofibromas. Ophthalmic: Lisch nodules, optic pathway glioma. Neurologic: learning disability, ADHD, seizures, headaches. Skeletal: scoliosis, bone dysplasia. Tumors: MPNST, astrocytoma, pheochromocytoma. Q. What are the radiologic findings? MRI brain may show optic pathway glioma and T2 hyperintense white matter lesions (“unidentified bright objects”). Plexiform neurofibromas appear as T2 target sign lesions. Q. How is NF1 managed? Observation for asymptomatic lesions. Surgical excision for symptomatic or disfiguring neurofibromas. Optic gliomas: observe unless progressive visual loss. When treatment is required for progressive vision loss or imaging advancement, chemotherapy (e.g., carboplatin/vincristine or BRAF/MEK inhibitors) is first-line; radiation is strictly avoided due to the high risk of secondary malignancies and moyamoya syndrome. Screening: annual BP, ophthalmology, and neuro exam; MRI only if symptomatic. MPNST suspicion: rapid growth, pain, or heterogeneity on MRI → biopsy. Q. What is the prognosis? Most live normal lifespans; risk of malignant transformation (MPNST) and vascular complications determine prognosis. Neurofibromatosis Type 2 (NF2) Q. What is the genetic basis of NF2? NF2 is caused by mutations in the NF2 gene on chromosome 22q12, encoding merlin (schwannomin), a tumor suppressor that regulates cell–cell contact inhibition. Loss of merlin leads to Schwann cell overgrowth and meningeal proliferation. Q. What is the inheritance pattern? NF2 is autosomal dominant with variable expression and near-complete penetrance by age 60. Around 50% are de novo mutations, and one-third of those are mosaic. Q. What are the diagnostic criteria for NF2-related schwannomatosis (updated 2022)? Diagnosis can be made by: 1. Bilateral vestibular schwannomas, or 2. A first-degree relative with NF2-related schwannomatosis plus either - unilateral vestibular schwannoma, or - any two of: meningioma, schwannoma, glioma, neurofibroma, or juvenile cataract. 3. NF2 pathogenic variant in blood or tumor, with compatible clinical features. Q. What are supportive clinical features of NF2? Bilateral vestibular schwannomas (pathognomonic). Multiple meningiomas (intracranial and spinal). Spinal ependymomas and schwannomas. Ocular: posterior subcapsular cataract, epiretinal membranes, retinal hamartomas. Cutaneous: plaque-like or subcutaneous schwannomas (no café-au-lait spots). Cranial neuropathies and hearing loss as early symptoms. Family history of early-onset hearing loss or CNS tumors. Q. What is the typical age of presentation? Adolescence or early adulthood, though pediatric onset may occur in mosaic NF2. Q. What are the imaging findings? MRI Brain/IAC: bilateral vestibular schwannomas, multiple meningiomas. MRI spine: intradural extramedullary schwannomas, ependymomas, or meningiomas. Q. How is NF2 managed? MRI surveillance (brain and spine every 12–24 months). Microsurgery or radiosurgery for symptomatic tumors. Bevacizumab for progressive vestibular schwannomas to reduce growth and improve hearing. Rehabilitation with cochlear or brainstem implants for hearing loss. Genetic counseling for family. Q. What is the prognosis? Progressive and multisystemic; median life expectancy around 60 years. Morbidity arises from bilateral hearing loss and brainstem compression. Schwannomatosis Q. What is schwannomatosis? Schwannomatosis is a rare tumor predisposition syndrome characterized by multiple non-vestibular schwannomas without bilateral vestibular schwannomas. It is now considered part of the NF2-related schwannomatosis spectrum. Q. What is the genetic basis? Three defined molecular subtypes: 1. NF2-related schwannomatosis – NF2 gene mutation (chromosome 22q12). 2. SMARCB1-related schwannomatosis – SMARCB1 mutation (chromosome 22q11.23). 3. LZTR1-related schwannomatosis – LZTR1 mutation (chromosome 22q11.23). Tumorigenesis follows a four-hit, three-step model: biallelic loss of both NF2 and one modifier gene (SMARCB1 or LZTR1) in the same cell. Q. What is the inheritance pattern? Autosomal dominant with incomplete penetrance and variable expressivity. Many cases are sporadic. Q. What are the diagnostic criteria (2022 update)? Clinical diagnosis: - Two or more non-intradermal schwannomas confirmed histologically. - No bilateral vestibular schwannomas on MRI. - No constitutional NF2 mutation or first-degree relative with NF2. Molecular diagnosis: - Pathogenic variant in SMARCB1, LZTR1, or NF2, in germline or mosaic form, without bilateral vestibular involvement. Q. What are the clinical features? Chronic or paroxysmal pain (hallmark symptom). Palpable nerve masses along peripheral or spinal nerves. No vestibular or hearing symptoms. Minimal skin lesions, no café-au-lait spots or Lisch nodules. May have mononeuropathies or focal weakness due to nerve compression. Q. What are the radiological features? MRI: multiple enhancing schwannomas along peripheral or spinal nerves, no vestibular schwannomas. Diffusion and contrast help differentiate from meningiomas or neurofibromas. Q. What are the histopathological findings? Typical schwannoma pattern: - Antoni A and Antoni B areas. - Verocay bodies in Antoni A. - Strong S-100 positivity. - No entrapped axons (unlike neurofibroma). Q. What are the differences among genetic subtypes? SMARCB1-related: early onset, spinal schwannomas, occasional meningiomas. LZTR1-related: peripheral nerve tumors, occasional unilateral vestibular schwannoma. NF2-related: mosaic or milder NF2 phenotype. Q. How is schwannomatosis managed? Surgical resection of symptomatic schwannomas. Pain control with neuropathic agents and nerve blocks. MRI surveillance every 2–3 years. Genetic counseling for family. No established drug therapy; bevacizumab is ineffective except in NF2-related cases. Q. What is the prognosis? Excellent life expectancy; main morbidity is chronic neuropathic pain and recurrent surgeries. Histologic Discussion: Schwannoma vs Neurofibroma Q. How do schwannoma and neurofibroma differ? Schwannoma: encapsulated, eccentric to nerve, purely Schwann cells, Antoni A/B areas, Verocay bodies, strong S-100, no axons, enucleable, rare malignancy. Neurofibroma: unencapsulated, intraneural, mixed cell types with axons inside, patchy S-100, CD34 positive stroma, “shredded carrot” collagen, plexiform type has MPNST risk. Target sign on MRI typical for neurofibroma; heterogeneous appearance for schwannoma. Q. What are Antoni A and Antoni B areas, and Verocay bodies? Antoni A areas are hypercellular and organized with nuclear palisading. Antoni B areas are hypocellular, myxoid, and loosely arranged. Verocay bodies are rows of palisaded nuclei separated by acellular eosinophilic zones of Schwann cell processes, pathognomonic for schwannoma. Q. What is segmental or mosaic NF? A postzygotic mutation causing localized disease limited to one body segment; germline mosaicism can still transmit generalized NF to offspring. Q. What is plexiform neurofibroma and why is it significant? Pathognomonic of NF1, involving multiple fascicles (“bag of worms”). Carries 10–15% risk of malignant transformation to MPNST. Q. What is MPNST? A high-grade sarcoma arising from plexiform neurofibroma or peripheral nerve sheath, characterized by pain, rapid growth, and heterogeneous MRI appearance. Genetic mechanisms of tumorigenesis: Both NF1 and NF2 follow the two-hit tumor suppressor model; loss of both alleles (somatic and germline) causes tumor formation. NF1: RAS pathway dysregulation. NF2: loss of contact inhibition via merlin deficiency. Follow-up protocols: NF1 – annual BP, neuro and eye exams, MRI if symptomatic. NF2 – MRI brain/IAC annually, spine every 2–3 years, audiology yearly. Schwannomatosis – MRI every 2–3 years, pain and nerve function monitoring. Final recall summary: NF1 = Peripheral + Pigmentary. NF2 = Central + Vestibular. Schwannomatosis = Multiple Painful Schwannomas, No Vestibular Involvement.

Explore Global Neurosurgery Conversations by The Neurosurgical Case Room (TNCR), bringing together neurosurgeons worldwide for academic dialogue, shared perspectives and international collaboration. Global Neurosurgery Conversations A flagship series featuring neurosurgeons from across the world, exploring training, surgical philosophy, and the mindset behind excellence. Episode 1 | Across the Divide | Robert Spetzler View All Conversations → Episode 2 | Beyond Resources | Mustafa Baskaya Episode 2 of Global Neurosurgery Conversations features Dr. Mustafa K. Baskaya, MD, a tenured Professor of Neurological Surgery at the University of Wisconsin and past chair of the International Division of the Congress of Neurological Surgeons (CNS). He is globally celebrated for his work in complex cerebrovascular and skull base surgery, driven by an uncompromising emphasis on microsurgical anatomy and technological discipline. Episode 3 | The Long Bridge | Jacques Morcos In Episode 3 of Global Neurosurgery Conversations, Dr Kanwal Ali hosts Professor Jacques Morcos to explore how neurosurgeons are trained across different healthcare systems worldwide. Professor Morcos is Chairman of Neurosurgery at UTHealth Houston, Director of Cerebrovascular and Skull Base Surgery, and President of the World Federation of Skull Base Societies. With decades of experience in global neurosurgical education, he shares deep insights into mentorship, training standards, and building excellence across diverse environments. Episode 4 | James Rutka | A Thousand Kilometers for a Surgeon In Episode 4 of Global Neurosurgery Conversations, Dr Kanwal Ali hosts Professor James T. Rutka for a deeply reflective discussion. Beyond techniques and titles, this conversation explores the human side of neurosurgery — the sacrifices, distance, ambition, mentorship, loneliness, leadership, and personal cost behind building a life in academic surgery. Professor Rutka shares insights from decades of experience as a pediatric neurosurgeon, academic leader, researcher, former President of the AANS, and long-time Editor-in-Chief of the Journal of Neurosurgery.

Explore myelomeningocele with The Neurosurgical Case Room (TNCR), including embryology, clinical presentation, associated anomalies, hydrocephalus and principles of surgical management. Myelomeningocele A myelomeningocele is an open spinal dysraphism resulting from failed primary neurulation, where the neural placode lies on the surface without skin or bone covering. The spinal cord and meninges herniate through a posterior vertebral defect, exposing neural tissue to the external environment. It is the most severe form of spina bifida compatible with life. Q. How is myelomeningocele different from myeloschisis? In myelomeningocele, neural tissue protrudes and forms a placode attached to the skin edge, sometimes elevated above surrounding levels. In myeloschisis, there is no sac, and the open neural plate lies flush with the skin surface, representing the most severe form of non-closure. Q. What is the embryological basis of myelomeningocele? It results from failure of primary neurulation during the 3rd–4th week of gestation, leading to non-fusion of neural folds and continued exposure of neural ectoderm. Subsequent absence of dysjunction prevents mesenchymal migration, leading to failure of vertebral arches, muscle, and skin formation over the neural tube. The exposed placode then protrudes through the defect. Q. What is the epidemiology of myelomeningocele? Incidence ranges 0.5–1 per 1000 live births globally, higher in regions with nutritional deficiencies. Females are slightly more commonly affected. Folic acid deficiency, maternal hyperthermia, diabetes, and valproate exposure significantly increase risk. Recurrence risk in subsequent pregnancies is 2–3%. Q. What anatomical levels are most commonly affected? The lumbar region is most commonly involved, followed by lumbosacral, thoracic, and cervical regions. Higher-level lesions result in more severe neurological deficits. Q. What clinical features are seen at birth? Newborns present with a skinless sac containing neural placode and CSF. Neurological deficits correspond to lesion level: motor weakness or paralysis, sensory impairment, areflexia, neurogenic bladder and bowel dysfunction, and orthopedic deformities. Associated anomalies include Chiari II malformation, hydrocephalus, syringomyelia, and corpus callosum dysgenesis. Q. What skin findings help differentiate an open MMC from closed dysraphism? An open MMC always has no skin covering, exposed placode, and CSF leak. Closed dysraphisms are skin-covered and lack exposed neural tissue. Q. What are the common associated intracranial abnormalities? Chiari II malformation, hydrocephalus, aqueductal stenosis, corpus callosum agenesis/hypoplasia, brainstem kinking, small posterior fossa, ventriculomegaly, and syringomyelia. Q. How do you investigate a newborn with myelomeningocele? MRI spine after closure to assess associated tethered cord; MRI brain to assess Chiari II and hydrocephalus; head ultrasound if unstable; renal ultrasound; urodynamic studies; orthopedic assessment. Q. How is myelomeningocele diagnosed antenatally? Antenatal diagnosis is achieved through elevated maternal serum AFP, targeted obstetric ultrasound showing lemon sign, banana sign, ventriculomegaly, and spinal defect. Fetal MRI further delineates hindbrain herniation and lesion extent. Early diagnosis enables counseling, consideration of in utero repair, and planned delivery at specialized centers. Q. How will you counsel the mother of a child with MMC pre-operatively regarding management and expectations? I will explain that MMC requires early closure within 24–48 hours to prevent infection and protect neural tissue. Neurological deficits present at birth will not reverse and hydrocephalus evaluation and treatment may be required. Long-term risks include tethered cord, orthopedic deformities, and neurogenic bladder. I will outline a multidisciplinary plan involving neurosurgery, urology, orthopedics, and rehabilitation. I will also discuss risks of CSF leak, infection, wound issues, and the need for long-term follow-up. Q. How will you manage a newborn with myelomeningocele at birth? Sterile saline dressings, prone positioning, antibiotics, evaluation for hydrocephalus, and urgent closure within 24–48 hours. Q. When will you operate on myelomeningocele? Within 24–48 hours to prevent infection and neural injury and to allow early hydrocephalus management. In patients with Myelomeningocele (MMC), hydrocephalus is managed through a combination of clinical surveillance, surgical CSF diversion, and careful timing relative to the spinal closure. 1. Clinical & Radiological Evaluation Pre- and Post-Closure Surveillance: Monitor head circumference daily, assess fontanelles for fullness/bulging, evaluate the spinal wound for CSF leakage or tension, and observe for signs of raised ICP (irritability, vomiting, poor feeding, sunsetting eyes). Neuroimaging: Baseline cranial ultrasound or rapid-sequence MRI is performed to evaluate ventricular size, brainstem distortion (Chiari II malformation), and aqueductal stenosis. Post-spinal closure imaging is routinely repeated as hydrocephalus often manifests or worsens after MMC repair. 2. Timing of Hydrocephalus Treatment - Simultaneous vs. Staged Repair: Staged Repair (Most Common): MMC closure is performed first (within 24–48 hours of birth). The child is then monitored closely, and CSF diversion is performed only if overt signs of hydrocephalus or wound breakdown develop. Simultaneous Repair: Reserved for infants presenting with severe, obvious hydrocephalus (marked ventricular enlargement or high fontanelle tension) at birth to prevent high CSF pressure from causing spinal repair breakdown or CSF leakage. 3. Surgical Modalities Ventriculoperitoneal (VP) Shunt: Gold Standard / Primary Option: Historically and currently the most common treatment (~80% of MMC infants eventually require a VP shunt). Valve Selection: Programmable valves with anti-siphon devices are preferred to minimize complications over time. Endoscopic Third Ventriculostomy with Choroid Plexus Cauterization (ETV/CPC): Alternative to Shunting: Combining ETV with CPC significantly improves success rates in infants under 6 months compared to ETV alone. Indication: Preferred in selected patients to avoid lifelong shunt dependency, particularly when aqueductal stenosis is present and the prepontine cistern is patent on imaging. 4. Associated Considerations (Chiari II & Wound Integrity) Chiari II Malformation: Hydrocephalus exacerbates hindbrain herniation. Decompressing the ventricles often improves Chiari II-related symptoms (stridor, vocal cord paralysis, apnea, or swallowing difficulties). Spinal Repair Protection: Untreated hydrocephalus increases back wound tension, leading to CSF fistula formation and a dramatically higher risk of meningitis. Controlling ventricular pressure directly protects the spinal closure site. Surgical Technique for MMC Closure: I will begin by positioning the newborn prone with the sac well protected on a sterile, moist dressing. I will pad the chest, pelvis, and extremities, ensuring no pressure is placed on the exposed neural placode. After wide antiseptic preparation, I will drape the entire back to allow free mobilization of soft tissues. I will first outline the incision. I will plan a fusiform elliptical incision around the base of the sac, incorporating dysplastic or epithelialized skin while preserving as much healthy skin as possible for closure. I will incise circumferentially through the epithelial–neural junction. As I deepen the incision, I will enter the sac if present and allow CSF to drain in a controlled fashion. Once the sac is opened, I will widely expose the underlying neural placode. At this point, I will use the operating microscope. I will carefully examine the placode to identify the true neural tissue and distinguish it from adherent membranes or epithelium. I will use sharp microsurgical dissection to separate the placode margins from the epithelialized skin. These adhesions may be delicate or fibrous, and I will free the neural edges circumferentially until the placode is completely mobilized from the surrounding tissues. If there is a transitional zone where skin or fibrous tissue blends with the placode, I will sharply define this interface to prevent tethering at closure. Once the placode is circumferentially free, I will begin the neural reconstruction. I will gently lift the lateral margins of the placode and identify the medullary folds. Using microforceps and fine sutures if needed, I will approximate these lateral neural folds toward the midline. My goal will be to re-tubularize the neural plate into a closed neural tube configuration. I will avoid traction, twisting, or compression on the neural tissue. If the placode is wide and cannot be completely tubularized, I will approximate it as much as safely possible to reduce its exposed surface and create a smooth contour under the dura. I will then focus on reconstructing the dura. I will identify the dysplastic dura around the margins of the bony defect. Using meticulous sharp and blunt dissection, I will separate the dura from underlying neural tissue, especially where it may be fused to the placode due to the congenital defect. This step requires careful attention to avoid injuring neural elements. I will extend the dissection laterally and inferiorly to mobilize the dura until I obtain edges that can be approximated without tension. If the dura is insufficient or too thin, I will harvest or place a dural substitute. I will perform a watertight dural closure using fine interrupted sutures, ensuring no gaps are left that could cause postoperative CSF leakage. I will ensure the reconstructed neural tube lies comfortably within the dural sac without compression or angulation. After completing the dural layer, I will address the muscle and fascial closure in multiple layers. I will mobilize the paraspinal muscles from their attachments along the defect, elevating them as needed to achieve a midline advancement. I will approximate the muscle and fascia layers over the dural repair in a tension-free manner to create robust, vascularized coverage. I will ensure no dead space remains that could predispose to CSF pooling or infection. I will reassess the remaining skin to ensure it can be closed without tension. If primary closure is possible, I will perform a layered closure with careful attention to preserving skin vascularity. For larger defects or tight margins, I will design rotational or advancement flaps to achieve a tension-free, well-perfused skin closure. I will verify that the final closure sits comfortably over the reconstructed dura and neural tube without tension points. Postoperatively, I will keep the infant prone and monitor closely for CSF leakage, wound breakdown, and hydrocephalus progression. I will initiate early evaluation by urology and orthopedics, and arrange follow-up imaging to assess the repair and guide decisions regarding shunt placement if hydrocephalus develops. Q. How will you close the myelomeningocele defect? I will try closing the defect in at least 5 layers. After re-tubularizing the neural placode, I will first achieve a watertight dural closure, either primarily or with a dural graft. The second layer is reconstruction of the lumbodorsal fascia or thoracolumbar fascia, which I will approximate over the dura when present. The third layer consists of paraspinal muscle advancement, where I will mobilize and bring the muscle bellies to the midline to provide vascularized coverage. The fourth layer is the subcutaneous tissue, which I will gently approximate without tension to eliminate dead space. The fifth and final layer is the skin, which I will close directly or with rotation/advancement flaps to ensure a tension-free, well-perfused final closure. Q. What are the perioperative complications during repair of myelomeningocele? Perioperative complications include injury to neural tissue during placode dissection, excessive bleeding from dysplastic dura or paraspinal muscles, temperature instability in the neonate, anesthetic difficulties including airway or ventilation issues in prone positioning, inadvertent CSF loss causing hemodynamic instability, difficulty achieving dural mobilization leading to incomplete watertight seal, vascular compromise of skin flaps, and placode torsion or kinking during re-tubularization. Intraoperative contamination of the exposed neural tissue or sac can increase risk of meningitis. Large defects may also predispose to venous bleeding from epidural plexus, and thoracic lesions may risk respiratory compromise. Some infants develop intraoperative apnea or bradycardia related to Chiari II brainstem dysfunction. Q. What postoperative complications may occur after MMC repair? Postoperative complications include CSF leak, pseudomeningocele, wound dehiscence, superficial or deep wound infection, and meningitis. Hydrocephalus may progress, requiring early VP shunt placement. Tethered cord can develop later due to scarring at the repair site. Skin flap necrosis may occur if closure was under tension. Shunt-related issues include infection, obstruction, or over-drainage. Respiratory dysfunction can worsen in infants with severe Chiari II, and urological deterioration may occur due to neurogenic bladder. Long-term complications include retethering, syringomyelia, and chronic pain. Q. What is the prognosis after MMC repair? Depends on lesion level, early closure, hydrocephalus control. High lumbar/thoracic lesions have poor ambulation; lower lesions may walk. Lifelong tethering risk persists. Renal preservation depends on early urological care. Cognitive outcome relates to hydrocephalus and brain anomalies. Q. What is the MOMS Trial and what were its key findings? The Management of Myelomeningocele Study (MOMS Trial) was a landmark randomized controlled trial comparing prenatal (in utero) repair of myelomeningocele with standard postnatal repair. It demonstrated that prenatal repair significantly reduced the need for ventriculoperitoneal shunting, improved hindbrain herniation associated with Chiari II malformation, and improved motor outcomes at 30 months of age. However, prenatal repair carried increased maternal risks including uterine dehiscence, preterm birth, and complications related to hysterotomy, limiting its applicability to highly selected centers and patients. Q. How will you counsel parents regarding the risk of recurrence in subsequent pregnancies? Recurrence risk is 2–3% after one affected pregnancy and around 10% after two affected pregnancies. High-dose folic acid (4 mg/day) one month pre-conception through the first trimester reduces recurrence by ~70%. Genetic counseling is recommended. Q. What are the recent advancements in management, including in utero surgery? Advancements include fetal surgery (open or fetoscopic) modeled after the MOMS Trial. Benefits include reduced hindbrain herniation and shunt dependence. Risks include maternal morbidity and preterm birth. Minimally invasive fetoscopic approaches are evolving, with improved perioperative fetal monitoring and neonatal support.

Review cervical laminoplasty with concise neurosurgical notes covering indications, patient selection, surgical techniques, operative principles, complications, and outcomes. Cervical Laminoplasty Q. What are the indications for cervical laminoplasty? Indications for cervical laminoplasty include: Multilevel cervical spondylotic myelopathy (CSM): Provided the patient has preserved lordosis or neutral sagittal alignment. Multilevel ossification of the posterior longitudinal ligament (OPLL) or congenital canal stenosis: When motion preservation is preferred over multi-level fusion. Resection of extensive spinal cord tumors: Where posterior access is needed, but total removal of the posterior arch would risk post-laminectomy instability or deformity (e.g., in pediatric populations). Q. What are the contraindications to cervical laminoplasty? The contraindications include: Preoperative cervical kyphosis (> 10 - 15 degrees): Laminoplasty relies on the spinal cord shifting backward away from the front of the spine. If the neck curves forward (kyphosis), the spine acts like a tight ridge, preventing the cord from drifting back and staying decompressed. Segmental or overt instability: Spondylolisthesis or hypermobility requires formal instrumented fusion. Focal anterior/unilateral pathology: Isolated single-level disease better addressed via ACDF. Severe axial neck pain or advanced osteoporosis: Poor bone quality risks hinge fracture/nonunion, and pre-existing axial pain often worsens postoperatively. Prior posterior cervical surgery: Incomplete or compromised laminar integrity. Q. What are the types of cervical laminoplasty, and when is each used? There are two main types: Open-Door (Hirabayashi Technique): A hinge is created at one lamina-facet junction while the contralateral side is cut completely to elevate the lamina. It is technically simpler and preferred for asymmetric stenosis or when unilateral lateral access is required. Double-Door / French-Door (Kurokawa Technique): The spinous processes are split down the midline, and bilateral partial-thickness hinges are created laterally to open the laminae symmetrically like double doors. It is preferred for central, symmetric stenosis or midline-predominant OPLL, offering superior muscle balance. Q. What are the advantages and disadvantages of Open-Door (Hirabayashi) laminoplasty? Advantages: Technically Simpler: Requires creating only a single lateral hinge and one contralateral open trough, making execution faster and technically less demanding. Unilateral Exposure: Allows preferential enlargement on the side of maximal clinical or radiographic compression. Direct Foraminal Access: Provides unhindered access to perform a targeted posterior foraminotomy on the open side if unilateral root decompression is needed. Disadvantages: Asymmetric Canal Expansion: Canal enlargement is non-uniform, which can leave relative stenosis or inadequate decompression on the hinge side if not carefully positioned. Asymmetric Muscular Dissection: Unilateral detachment and elevation can lead to asymmetrical muscle strain and higher rates of persistent post-operative axial neck pain. Risk of Complete Hinge Fracture: Greensticking a single continuous hinge across multiple levels risks complete fracture, potentially converting the construct into an unstable free-floating laminar segment. Q. What are the advantages and disadvantages of Double-Door / French-Door (Kurokawa) laminoplasty? Advantages: Symmetrical Canal Expansion: Provides uniform, central expansion of the spinal canal, making it ideal for midline-predominant stenosis or extensive central OPLL. Symmetrical Muscle Balance: Preserves the lateral musculocutaneous attachments symmetrically on both sides, which minimizes muscular imbalance and reduces the severity of axial neck pain. Lower Hinge Stress: Splitting the stress across two partial-thickness lateral hinges (rather than one) reduces the likelihood of a catastrophic complete hinge fracture during elevation. Disadvantages: Technically More Demanding: Splitting the spinous process exactly down the midline without plunging into the underlying cord requires precise central burring and increased operative time. Limited Foraminal Access: Performing formal foraminotomies for severe, bilateral root compression is more difficult through the split midline access compared to the open-door technique. Midline Nonunion Risk: The split spinous process requires central reconstruction (using spacers, suturing, or small plates); failure of central union can lead to delayed door collapse or construct breakdown. Q. How will you perform a cervical laminoplasty? Positioning & Exposure: I will position the patient prone using a Mayfield 3-pin clamp in slight flexion, pad all pressure points, and prep/drape widely. I will make a midline posterior incision and perform subperiosteal dissection out to the lateral masses, taking care to preserve the muscular attachments at C2 and C7 to prevent postoperative deformity. Hinge & Open-Side Preparation: On the hinge side, I thin the outer cortex and cancellous bone at the lamina-facet junction using a high-speed burr, leaving the ventral cortex intact to act as a greenstick hinge. On the open side, I drill through both outer and inner cortices to create a complete trough, then cut the ligamentum flavum at the cranial and caudal borders. Laminar Elevation & Fixation: I gently elevate the lamina from the open side to expand the canal and achieve dural expansion. I secure the expanded arch using rigid titanium miniplates bridging the lamina to the lateral mass, fixed with self-tapping screws (2 mm x 4 - 6 mm). Closure: I confirm complete decompression and hinge integrity, achieve meticulous hemostasis, place a subfascial drain, and perform a robust layered closure of the nuchal musculature and fascia. Q. What miniplates and screws are used for fixation in laminoplasty? I use low-profile titanium laminoplasty plates (1.5 - 2 mm thick) contoured to hold the desired canal expansion. Fixed with self-tapping 2 mm screws (4 - 6 mm length), placing at least one screw into the lamina and one into the lateral mass. Alternatively, structural allograft blocks or hydroxyapatite spacers can be sutured to maintain the door opening. Q. What are the complications and technical pitfalls of cervical laminoplasty? Complications: Postoperative C5 nerve root palsy (5 - 12%), persistent axial neck pain, laminar re-closure with recurrent stenosis, loss of lordosis/postoperative kyphosis, dural tears/CSF leak, and epidural hematoma. Technical Pitfalls: Hinge Failure: Complete fracture of the hinge side during elevation (requires converted plate fixation) or under-drilling the hinge (prevents smooth elevation). Inadequate Trough Placement: Placing the open-side trough too far medially (leaves residual stenosis) or too far laterally (causes severe venous plexus bleeding). Fixation Failure: Using undersized or short screws that pull out, leading to door re-closure. Q. How will you manage the patient postoperatively after cervical laminoplasty? I will monitor baseline neurological function, inspect the wound, and track subfascial drain output (removing the drain within 24–48 hours once output drops below threshold). I will fit the patient with a soft cervical collar for 1–2 weeks for comfort and muscle rest, maintain a low threshold for investigating deltoid/biceps weakness (C5 palsy), and optimize pain control with multimodal analgesics and short-term muscle relaxants. Q. When will you start mobilization and physiotherapy? I mobilize the patient (sitting and ambulating) on postoperative day 1 wearing the soft collar. Active shoulder and elbow range-of-motion exercises begin immediately to mitigate C5 palsy risk and shoulder stiffness. Gentle, active neck range-of-motion starts after 2 weeks as soft tissue pain subsides, progressing to isometric neck strengthening around 4–6 weeks. Q. What activity restrictions and follow-up are advised? Restrictions: I restrict heavy lifting (>10 lb), abrupt neck movement, and driving for 4–6 weeks. Light activities resume at 3–4 weeks, while strenuous labor, heavy contact sports, or vigorous exercise are restricted for at least 3 months. Follow-up & Imaging: Plain cervical radiographs (AP/Lateral) are obtained at 4–6 weeks to verify plate stability, hinge healing, and maintained canal expansion. Postoperative MRI is reserved for incomplete recovery or new neurological symptoms. Serial alignment checks monitor for long-term sagittal balance loss.

Explore encephalocele with The Neurosurgical Case Room (TNCR), including classification, clinical presentation, imaging, associated anomalies and principles of surgical management. Encephalocele An encephalocele is a congenital cranial anomaly in which intracranial contents herniate through a defect in the skull or skull base. The sac may contain meninges and cerebrospinal fluid alone, or meninges with brain tissue. It represents a form of cranium bifidum due to failure of midline neural tube closure and subsequent failure of normal calvarial or skull-base ossification. Clinically, any congenital midline cranial or nasal mass in an infant must be considered an encephalocele until proven otherwise. Q. How do you distinguish the related terms cranium bifidum, meningocele, and encephalocele? Cranium bifidum refers to the underlying defect of skull formation, usually in the midline, resulting from failure of bone fusion. When only meninges and cerebrospinal fluid herniate through this defect, the lesion is called a cranial meningocele. When meninges and brain tissue herniate together, the lesion is termed an encephalocele. In practice, many lesions contain some gliotic brain and are described as meningoencephaloceles. Q. What is the embryological basis of encephalocele? Encephalocele results from defective closure of the rostral neural tube and failure of subsequent normal ossification of the cranial vault or skull base. When membranous ossification of the calvaria fails, vault defects arise; when endochondral ossification of the anterior or middle cranial base fails, basal defects arise. Through these persistent bony gaps, meninges and, often, brain tissue herniate under the influence of intracranial pressure and pulsation. The same disordered embryogenesis often produces associated malformations such as agenesis of the corpus callosum, Chiari malformations, and Dandy–Walker spectrum abnormalities. Maternal folate deficiency is a primary established etiology (along with hyperthermia and genetic ciliopathies). Q. How are encephaloceles classified anatomically (Suwanwela and Suwanwela classification)? Suwanwela and Suwanwela classify encephaloceles based on the anatomic site of the skeletal defect: 1. Occipital (Most common in Western populations, ~75–80%) 2. Frontoethmoidal / Sincipital (Most common in Southeast Asia): • Nasofrontal • Nasoethmoidal • Nasoorbital 3. Cranial Vault: • Interfrontal, anterior fontanelle, parietal, temporal, and orbital. 4. Basal (Herniate into the nasal cavity, epipharynx, or sphenoid sinus): • Transethmoidal • Sphenoethmoidal • Transsphenoidal • Sphenoorbital 5. Posterior Fossa (Infratentorial / suboccipital) Q. What are the key subtypes of frontoethmoidal encephalocele in Suwanwela’s system? Frontoethmoidal or sincipital encephaloceles are divided into nasofrontal, nasoethmoidal, and nasoorbital types. In nasofrontal encephalocele, the sac herniates through the fonticulus frontalis and lies above or anterior to the nasal bones. In nasoethmoidal encephalocele, the herniation passes through the foramen cecum into the prenasal space, between the nasal bones and the upper nasal cartilage. In nasoorbital encephalocele, the defect involves the medial orbital wall, and the sac protrudes toward or into the medial orbital region. This anatomical relationship determines the external appearance, the degree of hypertelorism and nasal deformity, and the direction of surgical access. Q. How will you evaluate a child with encephalocele clinically? I will begin with a detailed antenatal and perinatal history, including family history of neural tube defects, consanguinity, folate supplementation, and any prenatal ultrasound findings of cranial defects or associated anomalies. I will ask about seizures, feeding difficulty, respiratory distress, recurrent meningitis, and visual or developmental concerns. On examination, I will inspect the head and face for a midline or paramedian swelling, note its size, position, skin condition, and whether it enlarges with crying or Valsalva. I will palpate to assess consistency, reducibility, and a bony defect at its base, and I will look for transillumination. I will assess head circumference, fontanelle tension, and cranial sutures to screen for hydrocephalus or craniosynostosis. A full neurological examination will be performed, focusing on tone, power, cranial nerves, visual fixation, and developmental milestones. I will examine the spine for dysraphism and look for other congenital anomalies such as polydactyly, renal or abdominal masses, or ocular abnormalities that may indicate a syndromic encephalocele. Q. What investigations are needed for a child with encephalocele? I will obtain MRI of the brain and craniovertebral region as the key study to define the contents of the sac, the presence of functional cortex versus gliotic brain, communication with the ventricles, brainstem involvement, associated anomalies such as corpus callosum agenesis, Chiari malformations, Dandy–Walker malformation, or syringomyelia, and any hydrocephalus. CT with bone window will be done to delineate the exact size and location of the bony defect, the anatomy of the anterior cranial fossa and paranasal sinuses in frontoethmoidal or basal lesions, and the occipital bone in posterior encephaloceles. For large occipital encephaloceles, MR venography or CT venography is important to define the relationship of the sac to the torcular Herophili and major dural venous sinuses. In anterior and basal lesions I will consider CT angiography or MR angiography if there is concern about proximity to anterior cerebral or ophthalmic arteries. In significant craniofacial deformity I will obtain three dimensional CT reconstructions for craniofacial planning. Baseline laboratory tests are obtained for anesthesia; endocrine and ophthalmologic evaluations are considered for basal and syndromic cases. In the presence of multiple anomalies or a suggestive pattern, I will involve genetics and arrange karyotyping or targeted panels. Q. How will you differentiate encephalocele from a midline growing skull fracture clinically and radiologically? Encephalocele is a congenital lesion present at or soon after birth, usually with no preceding trauma, and is often midline in the occipital or frontoethmoidal region. The overlying skin may be thinned but is usually intact at birth. The defect margins on imaging are smooth and corticated, representing a primary bone-formation failure, and the sac often communicates with a ventricle or subarachnoid space as a true herniation of intracranial contents. In contrast, a growing skull fracture is acquired, with a clear history of head trauma in infancy followed by progressive enlargement of a cranial swelling over months. The lesion typically lies over a linear fracture, most often in the parietal or frontal bone, and radiology shows a diastatic fracture line with scalloped and progressively widened bony margins due to pulsatile brain and cerebrospinal fluid through an associated dural tear. In growing skull fracture the initial skin may show signs of previous hematoma, and the age at presentation is later, usually beyond a few months, unlike the immediate neonatal presentation of encephalocele. Q. What is Furstenberg sign and what is its significance? Furstenberg sign is the increase in size and pulsation of a nasal or frontonasal mass when the jugular veins are compressed, the child cries, or the Valsalva manoeuvre is performed. It indicates that the mass has an intracranial communication and is typical of a nasal or frontoethmoidal encephalocele. Dermoid cysts and nasal gliomas do not enlarge with jugular compression and therefore have a negative Furstenberg sign. A positive Furstenberg sign should alert you to treat the lesion as an encephalocele and avoid blind biopsy or aspiration. Q. What syndromes and associated anomalies are commonly seen with encephalocele? Encephaloceles are associated with a wide range of central nervous system and systemic anomalies. Common intracranial associations include hydrocephalus, agenesis or dysgenesis of the corpus callosum, Chiari malformations, Dandy–Walker malformation, heterotopias, and myelomeningocele. Systemic and syndromic associations include Meckel–Gruber syndrome, which combines occipital encephalocele with cystic renal dysplasia and polydactyly; Walker–Warburg syndrome with severe lissencephaly, eye anomalies, and muscular dystrophy; Fraser, Knobloch, and Roberts syndromes; as well as ciliopathies such as Joubert syndrome. Occipital encephaloceles feature prominently in several of these syndromes, and their presence should prompt evaluation for renal, hepatic, ocular, and limb anomalies. Q. How will you manage a child with encephalocele and what is the role of multimodality care? I will first stabilize the child, ensure airway and feeding are safe, and treat any active infection or meningitis. If hydrocephalus is present and tense, I will address it either with shunting or endoscopic third ventriculostomy depending on the underlying ventricular anatomy, often before large posterior encephalocele repair to reduce venous congestion and sac tension. Definitive management is surgical, but it must be planned in a multidisciplinary setting involving neurosurgery, craniofacial or plastic surgery, otolaryngology for basal and frontoethmoidal lesions, anaesthesia, neonatology, and genetics. The aims are to excise non-viable herniated tissue, preserve or reposition functional brain where possible, achieve a watertight dural closure, reconstruct the skull or skull base to restore barrier and support, and correct craniofacial deformities to the extent feasible. Timing is individualised; life threatening airway compromise, uncontrolled cerebrospinal fluid leak, or recurrent meningitis demand early surgery, whereas otherwise stable anterior vault lesions may be timed to balance neurodevelopmental safety and craniofacial growth. Postoperatively, the child requires long-term follow up for neurodevelopment, vision, seizure control, and shunt function if present. Q. What general surgical principles do you follow when repairing an encephalocele? Key Surgical Principles: 1. Management of Hydrocephalus First / Simultaneously: If hydrocephalus is present, treat it with VP shunting or ETV before or during encephalocele repair. Closing a large sac without controlling hydrocephalus dramatically increases the risk of CSF wound breakdown, pseudomeningocele, and acute intracranial hypertension. 2. Soft Tissue & Venous Preservation: Open the sac carefully away from major neural structures. Identify and protect major dural venous sinuses (e.g., torcular, transverse sinuses) that may be displaced into or near the neck of an occipital sac using pre-operative MRV/CTV. 3. Handling Herniated Contents: Non-functional, gliotic, or dysplastic tissue within the sac is safely resected. Functional cortex (more common in sincipital/vault lesions) must be preserved and gently reduced into the cranial vault if space allows. 4. Watertight Dural Closure: Achieve an absolute watertight duraplasty using autologous pericranium, fascia lata, or synthetic dural substitutes to eliminate CSF leakage. 5. Osseous & Soft Tissue Reconstruction: Reconstruct large bony gaps with autologous split calvarial grafts or rigid mesh (in older children) to prevent recurrent herniation and restore structural skull integrity. Q. Describe the surgical steps for a nasofrontal or frontoethmoidal encephalocele. I will plan the operation in conjunction with a craniofacial team. I will position the child supine with the head elevated and fixed in a horseshoe or paediatric head holder, taking care to avoid pressure on the sac. I will administer broad spectrum antibiotics and use a bicoronal scalp incision extending from one preauricular region to the other, reflecting the scalp and pericranium anteriorly to expose the frontal bone and the nasal root. I will fashion a frontal bone flap incorporating the superior orbital rims when needed to expose the anterior cranial fossa floor, the frontal lobes, and the dural attachment of the sac. I will gently dissect the sac from the nasal and orbital soft tissues, controlling small emissary veins, and then open the sac in a controlled manner. I will inspect the contents, preserve any functional frontal cortex that can be safely repositioned intracranially, and excise gliotic or non-viable tissue. I will disconnect the sac at the bony defect, then repair the dural defect with a watertight duraplasty using pericranium. I will reconstruct the anterior cranial fossa floor with an autologous bone graft, often harvested from the frontal bone, and reposition the frontal bone flap. When indicated, I will perform fronto-orbital advancement or nasal reconstruction to correct hypertelorism and nasal deformity. I will place a subgaleal drain if necessary and close the scalp in layers, ensuring minimal tension over the reconstructed region. Q. Describe the surgical steps for a basal encephalocele. The exact approach depends on whether the lesion is transethmoidal, sphenoethmoidal, or transsphenoidal. For a typical midline basal transethmoidal or transsphenoidal encephalocele, I will favour an endoscopic endonasal approach in collaboration with an experienced otolaryngology team. I will position the child supine with the head slightly extended and rotated as needed, and I will prepare and drape the nasal cavity. Using a binostril endoscopic approach, I will identify the nasal septum, turbinates, and sphenoethmoidal recess, then expose the skull-base defect by removing overlying mucosa and carefully drilling or curetting thin bone under endoscopic vision. I will identify the herniated sac, gently dissect it circumferentially from surrounding mucosa, and then open it in a controlled manner if needed to decompress; otherwise I will coagulate and divide its neck at the level of the skull base. I will repair the dural defect with an underlay graft of fascia or acellular dermis, followed by an onlay graft and a vascularised pedicled nasoseptal flap where anatomy permits. I will secure the reconstruction with fibrin sealant and nasal packing to buttress the flap. In larger lesions or those with complex anatomy, I may combine a limited transcranial frontobasal exposure to assist with intracranial disconnection and reinforcement of the dural repair. Postoperatively, I will maintain head elevation, avoid nose blowing or Valsalva, and monitor for cerebrospinal fluid leak or meningitis. Q. Describe the surgical steps for an occipital or posterior fossa encephalocele. I will position the child prone or in a park-bench position with the head fixed and the sac supported without compression. I will mark a midline occipital incision that encompasses the base of the sac but avoids the thinned dome. After careful dissection of the scalp and suboccipital muscles, I will expose the bony defect and the dural sac. I will identify any major venous sinuses entering the sac with reference to preoperative venography and dissect them gently. I will open the sac near its base to allow controlled cerebrospinal fluid drainage, inspect the contents, and identify cerebellar or occipital lobe tissue that may be functional. Gliotic and dysplastic tissue is excised, whereas a functional brain that can be repositioned is preserved. I will then excise the redundant sac wall and perform a generous, watertight duraplasty using pericranium or fascia lata. If the bony defect is large, I will reconstruct it with split calvarial bone grafts or leave a small defect if the dura is well supported and the child is very young. I will ensure meticulous haemostasis, place a subgaleal drain if needed, and close the wound in layers. When hydrocephalus is present, I will have already treated it or will place a shunt at the same sitting, depending on the intraoperative findings and ventricular status. Q. What factors determine prognosis in a child with encephalocele? Prognosis depends on the location of the encephalocele, the volume and functional status of the herniated brain, the presence of hydrocephalus, and the burden of associated anomalies or syndromes. Anterior and small vault encephaloceles that contain little or no functional brain and are repaired early with good reconstruction usually have favourable outcomes. Large occipital encephaloceles containing brainstem or significant cerebellar or occipital lobe tissue, especially in the context of syndromes such as Meckel–Gruber or Walker–Warburg, have a guarded prognosis with high mortality and significant neurodevelopmental impairment in survivors. The presence of severe hydrocephalus, refractory seizures, or major systemic malformations further worsens outcome. Early multidisciplinary management, careful imaging based planning, and meticulous dural and bony reconstruction can significantly improve survival and quality of life in appropriately selected patients.

Coming Soon.

Explore microneurosurgical anatomy with The Neurosurgical Case Room (TNCR) through structured learning resources focused on surgical anatomy, neuroanatomy and operative approaches. Microsurgical Anatomy Sylvian Fissure Anatomy Part 1 | Surface Anatomy & Key Landmarks Simplified This video simplifies the surface anatomy and key anatomical landmarks of the Sylvian fissure into clear, structured concepts essential for both microsurgical orientation and viva preparation. Sylvian Fissure Anatomy Part 2 | Microsurgical Dissection & Surgical Landmarks Simplified This video takes the next step from basic anatomy into practical surgical understanding, highlighting how the Sylvian fissure is approached, opened, and utilized as a key corridor in neurosurgery. Temporal Lobe Anatomy | Structure, Boundaries & Functions | Part 1 Understand the temporal lobe anatomy in a clear and simplified way in this Part 1 video. This session breaks down the structure, boundaries, and key features of the temporal lobe using a visual and easy-to-follow approach. Temporal Lobe Anatomy | Part 2 Build on your understanding of temporal lobe anatomy in this Part 2 video. This session continues the simplified breakdown, focusing on deeper anatomical relationships and clinically relevant structures. Frontal Lobe Anatomy In this video, we simplify the anatomy of the frontal lobe, focusing on key gyri, functional regions, and their clinical and surgical relevance. Insular Anatomy In this video, we simplify the anatomy of the insula, one of the most important yet often overlooked regions of the brain. Located deep within the Sylvian fissure, the insular cortex plays a critical role in neurosurgical approaches, particularly in insula tumors, epilepsy surgery, and vascular procedures. Basal Ganglia Anatomy | Part 1 In this video, we simplify the anatomy of the basal ganglia and related deep brain structures that are fundamental to neurosurgery, neuroradiology, and clinical neurology. Basal Ganglia Anatomy | Part 2 | Lentiform Nucleus and Thalamus In Part 2 of this Basal Ganglia Anatomy series, we simplify the anatomy of the lentiform nucleus and thalamus, two deep brain structures that are essential for neurosurgery, neuroradiology, and clinical neuroanatomy. This video focuses on the anatomical relationships of the putamen, globus pallidus, internal capsule, and thalamus, with an emphasis on practical understanding and surgical relevance. Third Ventricle Anatomy Simplified | Surgical Anatomy & Boundaries Master the anatomy of the third ventricle with a neurosurgical perspective. Learn its boundaries, walls, roof, floor, hypothalamus, thalamus, foramen of Monro, aqueduct of Sylvius, surrounding neurovascular structures, and key surgical landmarks. Ideal for neurosurgery residents, medical students, neuroanatomy learners, and board exam preparation. Lateral Ventricle Anatomy | Part 1 | Ventricular System, Boundaries & Neuroanatomy In Part 1 of this Lateral Ventricle Anatomy series, we simplify the anatomy of the lateral ventricles using cadaveric specimens and practical surgical correlations. This video builds a strong anatomical foundation for understanding ventricular surgery and deep cerebral anatomy. Anatomy of Lateral Ventricles | Part 2 In part 2, we cover the boundaries and relations of the lateral ventricle, discussing each part separately and trying to build a clearer understanding of anatomical orientation.

Review Failed Back Surgery Syndrome (FBSS) with concise neurosurgical notes covering causes, evaluation, imaging, differential diagnosis, and management options. Failed Back Surgery Syndrome (FBSS) Q. What is Failed Back Surgery Syndrome (FBSS)? Failed Back Surgery Syndrome (FBSS) refers to the failure of pain relief or persistent/recurrent back and radicular pain following lumbar spine surgery, most commonly after lumbar discectomy or decompression. It represents an unsatisfactory symptomatic outcome despite technically performed operative procedures. Q. What are the key etiologies you must consider? Diagnostic Errors: Inadequate preoperative work-up leading to surgical intervention for the wrong primary pain generator or misdiagnosed condition. Persistent or New Compression: Residual or recurrent disc herniation, surgery at the wrong anatomical level, adjacent-segment pathology, epidural scar formation/fibrosis, pseudomeningocele, or post-decompression segmental instability. Neural Injury Pain: Neuropathic deafferentation pain resulting from permanent or chronic intraoperative/preoperative nerve root injury (characteristically burning or ice-cold in quality). Infection & Inflammatory Causes: Postoperative discitis, epidural abscess, or chronic adhesive arachnoiditis. Extraspinal & Non-Neurological Generators: Sacroiliac (SI) joint dysfunction, facet joint arthropathy, or reflex sympathetic dystrophy (CRPS). Q. What differentials mimic FBSS after lumbar surgery? Recurrent disc herniation or recurrent spinal stenosis. Postoperative discitis or epidural abscess. Postoperative pseudomeningocele or dural tear. Sacroiliac (SI) joint-mediated pain (accounts for 15–30% of persistent low-back pain; confirmed via image-guided intra-articular block). Facet joint arthropathy and myofascial pain syndrome. Adjacent-segment disease (ASD) following previous lumbar fusion. Q. How will you evaluate a patient with suspected FBSS? Clinical History & Documentation Review: Re-take a detailed history focusing on the pain-free interval ("honeymoon period"), functional status, and red flags. Re-examine all preoperative imaging, surgical operative notes, and pathology report logs. Physical & Neurological Examination: Perform a rigorous motor, sensory, reflex, and tension sign evaluation alongside SI joint provocation maneuvers. Laboratory Investigations: Inflammatory markers including CBC, ESR, and C-reactive protein (CRP) to rule out occult discitis or infection. Imaging Work-Up: Plain Radiographs: AP, lateral, and dynamic flexion-extension views to assess lumbar alignment, sagittal balance, hardware integrity, and mechanical instability. Contrast-Enhanced MRI: Investigation of choice; gadolinium administration differentiates vascularized epidural scar tissue (enhances early) from non-vascularized recurrent/residual disc herniation (enhances late/peripherally). CT with Bone Windows: Delineates osseous anatomy, pedicle screw placement, fusion status, and foraminal osteophytes. Diagnostic Injections: Consider image-guided selective nerve root blocks or SI joint intra-articular local anesthetic injections to isolate the precise pain generator. Q. When is nonoperative management appropriate, and what does it include? Indications: Indicated when there is no progressive neurological deficit, persistent mechanical root compression, or structural spinal instability. Conservative Components: Pharmacotherapy: Multimodal analgesia including NSAIDs, muscle relaxants, and neuropathic pain agents (gabapentinoids, SNRIs); short course of oral corticosteroids in acute flares. Physical Therapy & Rehabilitation: Core strengthening, posture correction, and targeted physical therapy. Psychosocial Optimization: Address yellow flags (catastrophizing, depression, secondary gain) and optimize medical comorbidities. Targeted Interventions: Diagnostic/therapeutic epidural steroid injections, selective root blocks, SI joint injections, or spinal cord stimulation (SCS) for refractory neuropathic pain. Q. What are the indications for re-operation? Persistent or progressive radiculopathy/neurological deficit directly correlating with persistent or recurrent neural compression (residual/recurrent disc or lateral recess stenosis). Objective mechanical or radiological spinal instability (iatrogenic or progressive). Pseudomeningocele causing symptomatic neural compression or persistent CSF leakage. Hardware failure, malposition, or pseudoarthrosis following prior instrumented fusion. Note: Re-exploration and revision decompression/fusion approaches must be precisely matched to the underlying anatomical pathology. Q. How do postoperative complications of lumbar disc surgery relate to FBSS? Postoperative complications directly drive the development of FBSS. Unrecognized intraoperative complications; such as wrong-level surgery, incidental durotomy leading to pseudomeningocele, excessive traction causing nerve root injury, or aggressive bony resection causing iatrogenic instability, frequently manifest as chronic post-surgical pain. Late complications including postoperative discitis, epidural fibrosis, and recurrent disc herniation form the core pathological bases of FBSS. Q. What imaging/lab clues suggest discitis as a cause of FBSS? Clinical Course: Classic history of a transient pain-free "honeymoon" period followed by severe, intractable back pain developing 2–6 weeks postoperatively, often accompanied by low-grade fever and constitutional symptoms. Laboratory Markers: Markedly elevated ESR and C-reactive protein (CRP) levels (CRP is particularly sensitive for early detection and monitoring treatment response). Radiographic & MRI Clues: Plain Radiographs (late): Disc space height loss, endplate erosion, and subchondral sclerosis/blurring. Contrast MRI (gold standard): Fluid signal/hyperintensity on T2-weighted images within the disc space, intense enhancement of adjacent vertebral endplates and subchondral bone marrow (T1 hypointensity/edema), and disc enhancement post-gadolinium. Confirmation: Image-guided biopsy and culture to tailor targeted antimicrobial therapy. Q. What else can masquerade as FBSS that you should actively look for? Postoperative Epidural Abscess: Presents with progressive severe axial pain, neurological deficits, or systemic sepsis. Adhesive Arachnoiditis: Chronic intrathecal inflammation characterized on MRI by clumping of lumbar nerve roots ("empty thecal sac" sign or central nerve root mass). Iatrogenic Spinal Instability: Unrecognized segment hypermobility following extensive facetectomy or laminectomy. Management Principles: Systemic infections require surgical debridement, evacuation, long-term targeted antibiotic therapy, and instrumented stabilization when structural integrity is compromised. Q. What is your stepwise management algorithm? Reassess & Re-image: Detailed clinical evaluation, review of previous op notes, inflammatory markers (ESR/CRP), dynamic X-rays, CT bone windows, and contrast-enhanced MRI. Rule Out Sepsis, Wrong Level, & Extraspinal Generators: Exclude discitis/abscess and wrong-level intervention; perform targeted diagnostic injections (e.g., SI joint or selective root blocks) when non-spinal pain generators are suspected. Institute Conservative Care: If mechanical compression or instability is absent, utilize multimodal pharmacotherapy, targeted physiotherapy, interventional pain procedures (including spinal cord stimulation), and psychosocial optimization. Surgical Intervention: Re-operate for proven structural lesions; persistent or recurrent nerve compression, progressive motor deficit, or radiologically proven mechanical instability (adding instrumented fusion and stabilization as indicated). Q. What are the outcomes? Outcomes depend heavily on accurate identification and isolation of the primary pain generator. While primary microdiscectomy carries a high success rate (88–98.5%), revision procedures for FBSS have lower success rates and higher complication profiles. FBSS highlights the clinical and economic impact of misdiagnosis, unaddressed instability, and postoperative infection; early alignment of patient expectations with realistic functional goals is essential.

Explore cerebral abscess with The Neurosurgical Case Room (TNCR), including pathogenesis, clinical presentation, imaging, diagnosis and principles of medical and surgical management. Cerebral Abscess A cerebral abscess is a localized, focal, suppurative infection within the brain parenchyma that begins as an area of cerebritis and evolves into a collection of pus surrounded by a capsule. It represents the host’s attempt to contain infection. Q. What are the stages of evolution of a brain abscess? 1. Early cerebritis (1–3 days): Perivascular inflammation and necrosis, no capsule. 2. Late cerebritis (4–9 days): Expanding necrosis, peripheral fibroblast proliferation. 3. Early capsule (10–13 days): Capsule formation begins with fibroblast collagen deposition. 4. Late capsule (≥14 days): Thick collagen capsule surrounded by gliosis and reduced edema. Steroids slow capsule formation and should be avoided unless there is significant mass effect. Q. What are the routes of spread of infection? Which is most common? 1. Hematogenous spread (most common): From lung abscess, bronchiectasis, empyema, endocarditis, skin sepsis, pelvic infection, or cyanotic congenital heart disease. In congenital heart disease, right-to-left shunts bypass pulmonary filtration, allowing septic emboli to reach the brain. Usually results in multiple abscesses at the gray–white junction. 2. Contiguous spread (30–40 %): From sinusitis (especially frontal and sphenoid), otitis media, mastoiditis, or dental sepsis. Typically causes solitary abscess in adjacent lobe. 3. Direct inoculation: Post-neurosurgical procedures, compound fractures, or penetrating trauma. 4. Cryptogenic: No identifiable source (10–15 %). Q. What are the common causative organisms? Most common overall: Streptococcus species (esp. S. milleri group). Polymicrobial: Found in up to 60 % of cases. Anaerobes: Bacteroides, Peptostreptococcus, Fusobacterium. Gram-negative bacilli: Proteus, E. coli, Klebsiella, Pseudomonas. Neurosurgical procedures: Staphylococcus aureus, Staphylococcus epidermidis, Pseudomonas aeruginosa. Penetrating trauma: Clostridium, Staphylococcus aureus, Pseudomonas. In AIDS / immunocompromised: Nocardia, Toxoplasma gondii, Aspergillus, Candida, Mucor. Q. What are the common locations and their sources? Temporal lobe and cerebellum: Otitis media, mastoiditis Frontal lobe: Frontal or sphenoid sinusitis, dental sepsis Parietal lobe: Postoperative or post-traumatic Occipital lobe: Chronic pulmonary sepsis, cyanotic heart disease Multiple abscesses: Bacteremia or endocarditis Q. What investigations will you perform? CBC: Leukocytosis in ~60%. ESR / CRP: CRP elevation in nearly all; sensitivity ~97%, specificity ~80%. Blood cultures: Positive in 10–20%. CT brain with contrast: - Early cerebritis: Poorly defined hypodensity. - Mature abscess: Ring-enhancing lesion with smooth inner margin, hypodense center, vasogenic edema. - Double ring sign characteristic (outer capsule + inner granulation). MRI: - T1: Central hypointensity with enhancing capsule. - T2: Central hyperintensity with hypointense rim. - DWI: Restricted diffusion in abscess cavity (distinguishes from tumor necrosis). Leukocyte (HMPAO) scan: Localizes active suppuration and differentiates abscess from tumor or sterile cystic lesions. (Most accurate) MR spectroscopy: Shows lactate, acetate, and succinate peaks (unique to bacterial metabolism). Aspiration for culture and sensitivity is the diagnostic gold standard. Q. What are the imaging features distinguishing late cerebritis from early capsule stage? In late cerebritis, rim enhancement appears irregular and incomplete. In early capsule stage, the rim becomes smooth and complete with reduced central diffusion restriction. With steroid therapy, enhancement and perilesional edema may prematurely decline, making differentiation challenging. Q. What are the differential diagnoses of a ring-enhancing lesion? High-grade glioma, metastasis, tuberculoma, toxoplasmosis, subacute infarct, demyelination, or resolving hematoma. Q. How will you manage a case of cerebral abscess? 1. Medical management (selected cases only): Indications: - Abscess < 3 cm in diameter - No significant mass effect or midline shift - Glasgow Coma Scale > 12 - Etiology and organism known - Abscess in deep or eloquent area (thalamus, brainstem) not surgically accessible - Early cerebritis on imaging - Multiple small abscesses without mass effect - Post-surgical patients with sterile collections - Concomitant meningitis or ependymitis (surgery contraindicated until sterilization) Regimen: - Ceftriaxone 2 g IV q12h or Cefotaxime 2 g IV q6h - Metronidazole 500 mg IV q6h - Vancomycin 15 mg/kg IV q8–12h Duration: Minimum 6–8 weeks IV, continued until contrast enhancement resolves. Endpoint: Disappearance of enhancement and edema on serial MRI. Monitoring: ESR, CRP, weekly CT/MRI. Steroids: Avoid unless mass effect is severe; they delay capsule formation and antibiotic penetration. Q. What are the indications for surgical treatment? 1. Size > 3 cm 2. Neurological deterioration or low GCS 3. Mass effect or midline shift 4. Diagnostic uncertainty (to exclude tumor) 5. Failure of medical therapy after 2 weeks 6. Multiple abscesses with one dominant lesion 7. Superficial or traumatic abscess near dura 8. Posterior fossa abscess 9. Gas-containing abscess (suggests anaerobes) 10. Impending rupture into ventricles Contraindications: Concomitant meningitis or ependymitis until infection controlled Q. What are the surgical options? Needle aspiration (stereotactic or open) is the mainstay for most cases; allows decompression and culture with minimal morbidity. Excision (en bloc removal): Reserved for encapsulated abscesses near cortical surface, recurrent abscess, fungal or foreign-body-related lesions. Multiple abscesses: Target the dominant or largest lesion first, followed by staged aspirations. Penetrating trauma abscess: Debridement of necrotic brain and removal of foreign body, followed by prolonged antibiotics. Q. What are the key points in postoperative management? Serial CT or MRI every 48–72 h after aspiration. Continue IV antibiotics for minimum 8 weeks or longer until full radiologic resolution. Continue AEDs for 6 months (seizure prophylaxis). Manage ICP; if refractory, consider decompressive craniectomy. Treat and eradicate the primary focus (sinus, ear, dental, or cardiac source). Q. What are the complications of cerebral abscess? Rupture into ventricles (fatal in 80 %). Subdural or epidural empyema. Hydrocephalus. Seizures and focal deficits. Recurrence, especially with incomplete capsule removal or immunosuppression. Q. What is the prognosis? Mortality 10–20 %, prognosis is best with early diagnosis and adequate therapy. Neurological sequelae (hemiparesis, epilepsy) in up to 50 %. Fungal and multiple abscesses have poorer prognosis.

Explore cerebellopontine angle anatomy and pathology with The Neurosurgical Case Room (TNCR), including relevant cranial nerves, surgical anatomy, common lesions and operative approaches. Coming Soon.

Explore Chiari malformations with The Neurosurgical Case Room (TNCR), including classification, pathophysiology, clinical presentation, imaging and principles of surgical management. Chiari Malformations A Chiari malformation is a congenital or acquired hindbrain anomaly in which posterior fossa structures, particularly cerebellar tonsils, herniate through the foramen magnum into the cervical canal. This causes crowding, brainstem compression, and disturbance of CSF flow, leading to symptoms such as Valsalva-induced headache, cerebellar signs, cranial nerve dysfunction, or syringomyelia. The fundamental mechanism is a mismatch between posterior fossa volume and its neural contents, producing tonsillar impaction and dynamic obstruction of CSF pulsations. Multiple subtypes exist (0, I, 1.5, II, III, IV), each with distinct embryologic and radiologic characteristics. Q. What is the embryological basis of Chiari malformations? Chiari malformations originate from abnormalities in development of the occipital somites, paraxial mesoderm, and proatlas, producing inadequate posterior fossa volume. Other contributors include abnormal basioccipital development, low tentorial insertion, and segmentation defects at the craniocervical junction. The McLone and Knepper theory: In Chiari II, an open neural tube defect (spina bifida) causes chronic cerebrospinal fluid (CSF) leakage in utero. This fluid loss prevents the expanding pressure needed to grow the embryonic brain vesicles, resulting in a collapsed ventricular system and an abnormally small skull base (posterior fossa) that forces the developing hindbrain to herniate downward. Cranio-Cerebellar Disproportion Theory (Marin-Padilla): A developmental theory asserting that underdevelopment of the occipital bone creates an abnormally small posterior fossa skull base, physically crowding a normally growing hindbrain and forcing it to herniate downward. Molecular Genetic Theory: A biological theory suggesting that genetic mutations during early embryonic development disrupt skull bone formation (paraxial mesoderm), leading to a small skull base that forces normal brain tissue downward. Traction Theory (Penfield): An early, largely disproven mechanical theory proposing that a tethered spinal cord physically pulls the brainstem and cerebellum downward into the spinal canal. Q. How does Chiari malformation lead to syringomyelia? There are multiple theories for formation of syrinx in chiari malformation. 1. Water-Hammer Theory (Gardner’s Theory) It proposes that a blocked fourth ventricle outlet causes the pulse waves of cerebrospinal fluid (CSF) to act like a "water hammer," forcing fluid downward into the central canal of the spinal cord and expanding it into a syrinx. 2. Hydrodynamic Dissociation Theory (Williams’ Theory) It proposes that coughing, straining, or sneezing causes a sudden rise in venous pressure that pushes CSF upward. The Chiari malformation acts as a one-way valve, trapping that fluid in the spine and forcing it into the spinal cord tissue. 3. Piston Theory (Oldfield’s Theory) It proposes that the herniated cerebellar tonsils act like a piston during each heartbeat, downwardly compressing the spinal subarachnoid space and forcing CSF into the spinal cord tissue through spaces surrounding blood vessels (perivascular spaces). Oldfield’s Piston Theory is the most widely accepted mechanical model today for syrinx formation in Chiari malformations. 4. Pressure Gradient Theory (Ball and Dayan’s Theory) It proposes that the Chiari malformation creates a partial block at the skull base, causing a pressure difference where the fluid pressure outside the spinal cord is higher than inside, slowly filtering CSF into the spinal cord tissue. 5. Intramedullary Pressure Theory (Heiss’ Theory) It proposes that the piston-like movement of the herniated tonsils creates a localized, high-pressure fluid wave that physically damages spinal cord tissue, creating extracellular fluid accumulation that coalesces into a syrinx cavity. Q. What are the etiologies of Chiari malformations? Congenital/developmental: Mesodermal hypoplasia of the posterior fossa (most common), basilar invagination, platybasia, craniosynostosis (lambdoid/occipital), atlas assimilation, connective tissue disorders (Ehlers–Danlos, Marfan), and tethered cord causing craniospinal traction. Acquired/secondary: Intracranial hypotension (spontaneous leak or over-draining shunt), posterior fossa or hemispheric mass lesions, post-traumatic craniovertebral deformity, venous outflow obstruction, infection/arachnoiditis, and excessive prior decompression leading to cerebellar sag (acquired Chiari). Q. What are the etiologies of syringomyelia and their approximate association percentages? Chiari I malformation: 60–80% of syrinx cases. Chiari II malformation: 10–15%. Post-traumatic syringomyelia: 5–8% of chronic SCI patients. Post-infectious/adhesive arachnoiditis: 3–5%. Intradural/intramedullary tumors (ependymoma, hemangioblastoma, astrocytoma): 5–10%. Postoperative arachnoid scarring: <3%. Idiopathic: <2%. Principle: any pathology that obstructs or dissociates craniospinal CSF flow can generate a syrinx. Q. What is Goel’s theory and its surgical implication? Goel proposed that Chiari I is often secondary to atlantoaxial instability rather than primary posterior fossa hypoplasia. Tonsillar descent acts as an adaptive cushion (“natural airbag”) against C1–C2 micro-instability. Surgical implication: when instability is demonstrated, I will prioritize C1–C2 stabilization (Goel–Harms) which can restore brainstem relationships and lead to syrinx collapse, sometimes without posterior fossa decompression. Q. What is Chiari 0? Chiari 0 refers to patients with syringomyelia and symptomatic CSF flow obstruction at the foramen magnum who have no or minimal (<3 mm) tonsillar descent. Cine MRI shows characteristic flow impairment identical to that of Chiari I. Posterior fossa volume may be subtly small. Decompression often results in syrinx resolution. Q. What is Chiari I malformation? Chiari I is defined by ≥5 mm descent of cerebellar tonsils below the foramen magnum. The posterior fossa is small and shallow, resulting in tonsillar crowding. The medulla may kink, and CSF spaces around the foramen magnum become narrowed. Syringomyelia is common. Bone anomalies such as basilar invagination, atlas assimilation, and platybasia frequently coexist. Q. What is Chiari 1.5? Chiari 1.5 is a more severe form of Chiari I involving descent of both the cerebellar tonsils and the brainstem/medulla. It reflects significant posterior fossa crowding. Patients often have more aggressive symptoms, worse syringomyelia, and less predictable surgical outcomes unless a more generous decompression is performed. Q. What is Chiari II malformation? Chiari II is a complex malformation nearly universal in open myelomeningocele. The cerebellum, medulla, pons, and fourth ventricle herniate through the foramen magnum into an elongated cervical canal. Features include: Small posterior fossa Low tentorium Kinked brainstem Beaked tectum Elongated fourth ventricle Hydrocephalus (common) It results from early fetal CSF leakage, which collapses the ventricles and pulls hindbrain structures downward. Q. What is Chiari III malformation? Chiari III consists of a high cervical or occipital encephalocele containing cerebellum, brainstem, and occasionally occipital lobes. The foramen magnum is enlarged. Neurological outcomes are poor, and hydrocephalus is common. Q. What is Chiari IV malformation? Chiari IV is defined as severe cerebellar hypoplasia or aplasia without herniation through the foramen magnum, with normal posterior fossa structures and tentorium location. It is no longer considered a true Chiari malformation; it is categorized among cerebellar developmental disorders. Q. What are the clinical and imaging features of Chiari I? Clinical: Tussive suboccipital headache worsened by coughing or Valsalva Neck pain, dizziness, ataxia, dysmetria, downbeat nystagmus Dysphagia, dysarthria, sleep apnea (central or obstructive) Syringomyelia-related: dissociated sensory loss, hand weakness, spasticity, scoliosis Imaging: Tonsillar descent ≥5 mm Reduced posterior fossa volume and crowded foramen magnum Obliterated cisterna magna Associated findings: syrinx, scoliosis, basilar invagination Cine MRI shows ventral/dorsal flow blockage and reduced compliance. Q. What are the clinical and imaging features of Chiari 1.5? Clinical: More severe brainstem compression Bulbar symptoms: dysphagia, aspiration, central apnea, stridor More aggressive scoliosis Worse syrinx-related deficits Imaging: Caudal descent of tonsils and medulla Pointed medulla, more extreme crowding Severe CSF flow obstruction at the craniovertebral junction Q. What are the clinical and imaging features of Chiari II? Clinical: Neonatal apnea, stridor, weak cry, aspiration Cranial nerve dysfunction (VI, VII, IX, X, XII) Spasticity, developmental delay Nearly universal hydrocephalus Symptoms may improve with optimized CSF diversion Imaging: Herniated cerebellum and brainstem Low tentorium, beaked tectum Elongated fourth ventricle Associated MMC and spinal anomalies Q. What are the clinical and imaging features of Chiari III? Clinical: Severe neurological impairment Respiratory instability Often incompatible with long-term survival Imaging: Occipital/cervical encephalocele with hindbrain contents Posterior fossa dysgenesis Frequent hydrocephalus and venous anomalies Q. What investigations are needed in Chiari malformations? MRI brain and whole spine: tonsillar descent, syrinx, scoliosis, tethered cord Cine phase-contrast MRI: assess CSF flow blockage CT skull base/CVJ: basilar invagination, occipitalization, platybasia Dynamic cervical imaging: instability evaluation Polysomnography: apnea in Chiari I/II Urodynamics: syrinx-related autonomic dysfunction Q. How are Chiari I and Chiari 1.5 managed? Asymptomatic Chiari I: observe Symptomatic Chiari I or Chiari 1.5: posterior fossa decompression with C1 laminectomy and duraplasty Indicated especially for syringomyelia, brainstem compression, or severe cough headache Chiari 1.5 often requires more generous decompression due to brainstem descent Q. How is posterior fossa decompression performed? Positioning: I will position the patient prone on chest rolls with the head fixed in a Mayfield clamp in neutral to slight flexion, avoiding jugular compression. I will pad all pressure points and confirm neuromonitoring baselines. Incision and Exposure: I will make a midline vertical incision from the inion to mid-C2. I will elevate paraspinal/suboccipital muscles subperiosteally to expose the suboccipital bone, foramen magnum rim, and C1 posterior arch. Craniectomy: I will perform a midline suboccipital craniectomy approximately 3×3 cm, centered at the foramen magnum, strictly avoiding lateral extension to protect the vertebral arteries. C1 (± C2) Laminectomy: I will remove the posterior arch of C1. If the C2 posterior arch genuinely causes dorsal bony canal compromise, I will do a full C2 laminectomy (or C2 arch undercut). Dural Opening: I will perform a Y-shaped durotomy and tack up the edges. I will preserve the arachnoid when thin and normal; if thickened/adhesive, I will open it sharply under irrigation. Tonsillar Management: If the tonsils are peg-shaped and obstructing, I will perform gentle subpial bipolar coagulation/shrinkage in the medial portion only, avoiding lateral coagulation near the tonsillomedullary fissure (PICA territory). Duraplasty and Closure: I will perform an expansile duraplasty using pericranium or fascia to achieve a watertight closure. I will ask my anesthesiologist to perform a Valsalva maneuver to check for CSF leak, then I will close fascia and skin in layers and apply a pressure dressing, avoiding dead space to reduce pseudomeningocele risk. Q. How is Chiari II managed? First priority: closure of myelomeningocele Hydrocephalus management: VP shunt or ETV Posterior fossa decompression only if apnea, stridor, or swallowing difficulty persist despite optimized CSF diversion Outcomes depend heavily on intrinsic brainstem function rather than the decompression alone. Q. How is Chiari III managed? Surgical repair of the encephalocele CSF diversion as needed Prognosis remains poor Q. What complications can occur after Chiari decompression? Intraoperative: Venous sinus bleeding, vertebral artery injury, PICA or tonsillar arterial injury, accessory nerve traction injury, cerebellar/medullary contusion, excessive bone removal (cerebellar ptosis risk), air embolism (sitting position), inadequate decompression. Early postoperative: CSF leak/pseudomeningocele (most common), meningitis, wound infection, hydrocephalus, posterior fossa hematoma, transient neurological worsening. Late: Persistent/recurrent syringomyelia, craniocervical instability, cerebellar ptosis (over-decompression), adhesive arachnoiditis, graft failure/migration, recurrence from scarring or incomplete CSF flow restoration. Q. Which neurovascular structures are at risk during posterior fossa decompression and how will you protect them? Vertebral arteries: Course along the posterolateral foramen magnum and curve beneath the C1 arch; to avoid injury, I will confine bone removal to a strict midline window (typically <1.5 cm lateral from midline). Spinal accessory nerve (CN XI): Traverses beneath trapezius/superior oblique; I will keep muscle elevation subperiosteal and close to midline, minimizing lateral cautery/retraction. Posterior inferior cerebellar artery (PICA): Originates from the vertebral artery and runs in the tonsillomedullary fissure; I will limit coagulation to medial subpial tonsillar surfaces, use low bipolar current with irrigation, and avoid deep lateral dissection to prevent lateral medullary/cerebellar infarction. Q. How will you manage a persistent or recurrent syrinx after decompression? If postoperative MRI shows a persistent/enlarging syrinx, I will reassess CSF flow across the foramen magnum and look for arachnoid scarring. If residual obstruction exists, I will revise the decompression and perform arachnolysis. If CSF pathways are patent yet the syrinx remains symptomatic, I will consider shunting—preferably a syringosubarachnoid shunt; if unsuitable or failed, syringoperitoneal or syringopleural shunts may be used. Q. What is the prognosis after Chiari decompression? 70–90% of patients with Chiari I improve, especially headaches and syrinx-related symptoms Syrinx collapse typically occurs within 6–12 months Poorer prognosis with long-standing myelomalacia, severe scoliosis, or Chiari 1.5 Chiari II: outcome depends on hydrocephalus control and brainstem integrity Chiari III: neurological outcome generally poor

Explore craniovertebral junction anomalies with The Neurosurgical Case Room (TNCR), including relevant anatomy, clinical presentation, imaging, classification and principles of surgical management. CVJ Anomalies 1. Occipital–Atlas (C0–C1) Anomalies Atlanto-occipital assimilation (occipitalization of atlas) Hypoplastic occipital condyles Asymmetrical occipital condyles Condylar hypogenesis or aplasia Third condyle (accessory occipital condyle) Proatlas segmentation defects 2. Atlas (C1) Anomalies Anterior arch cleft of C1 Posterior arch cleft of C1 Complete absence of the posterior arch of C1 Split atlas (bipartite atlas) Hypoplastic atlas Megalatlas (enlarged C1) Hypertrophied posterior arch Congenital C1 canal stenosis 3. Axis (C2) and Odontoid Anomalies Os odontoideum Ossiculum terminale persistens (persistent ossicle of the dens tip) Odontoid aplasia Odontoid hypoplasia Odontoid hypertrophy (rare) Retroflexed odontoid Fused odontoid–body synchondrosis (failure of normal fusion) Absent dens + anterior arch of C1 fusion (rare congenital block) Dens bifid (split odontoid) 4. Basilar/Clival Anomalies Basilar invagination Platybasia Short clivus (clival hypoplasia) Chiari-associated basilar settling Abnormal basal angle (primary cranial base deformity) 5. Atlantoaxial (C1–C2) Anomalies and Instability Congenital atlantoaxial instability Congenital C1–C2 facet malformation Congenital C1–C2 rotatory subluxation (rare congenital type) 6. Foramen Magnum Anomalies Congenital foramen magnum stenosis Narrow foramen magnum in skeletal dysplasias Enlarged foramen magnum (less common variant) 7. Ligamentous/Soft-tissue Anomalies Transverse ligament laxity (congenital) Alar ligament hypoplasia Apical ligament deficiency Congenital ligamentous laxity in syndromic disorders (Down, Morquio). These predispose to atlantoaxial instability. 8. Developmental Fusion Disorders (Beyond C1–C2) Klippel–Feil syndrome (congenital cervical fusions involving CVJ) Occipital–C1–C2 congenital block vertebra Multilevel congenital block vertebrae with CVJ compensation 10. Syndromic CVJ Anomalies These are congenital syndromes that characteristically involve CVJ abnormalities. Down syndrome: Odontoid hypoplasia, transverse ligament laxity, atlantoaxial instability. Morquio syndrome (MPS IV): Severe odontoid hypoplasia, ligamentous laxity, atlantoaxial instability. Achondroplasia: Foramen magnum stenosis, short clivus, brainstem compression. Osteogenesis imperfecta: Basilar invagination, platybasia. Cleidocranial dysostosis: Occipital condyle anomalies, atlanto-occipital instability. Goldenhar syndrome: Occipital condylar anomalies. Spondyloepiphyseal dysplasia: Odontoid hypoplasia, CVJ instability. Craniosynostosis syndromes (Crouzon, Pfeiffer): Platybasia, basilar invagination, Chiari I. Neurofibromatosis type 1 Dysplastic C1–C2 anomalies Q. How do congenital CVJ anomalies develop embryologically? Congenital CVJ anomalies arise from improper segmentation of the occipital somites, failure of chondrification or ossification of the proatlas and sclerotomes, or persistence of cartilaginous synchondroses. The occiput derives from the proatlas and four occipital somites, while the atlas and axis derive from the first and second cervical sclerotomes. Errors in these developmental steps result in occipitalization of the atlas, basilar invagination, odontoid anomalies such as os odontoideum and odontoid hypoplasia, and congenital fusions or clefts of the atlas arches. Associated abnormalities such as Chiari I malformation or syringomyelia occur when reduced posterior fossa volume or ventral brainstem compression alters CSF flow across the foramen magnum. Q. What are the major congenital anomalies of the CVJ? The major congenital anomalies include atlanto-occipital assimilation, basilar invagination, platybasia, os odontoideum, odontoid aplasia or hypoplasia, C1 arch defects, congenital atlantoaxial instability, and syndromic abnormalities such as those seen in Klippel–Feil syndrome, Down syndrome, Morquio disease, and other skeletal dysplasias. These anomalies cause pathology either by producing instability or by producing ventral or dorsal compression at the cervicomedullary junction. Q. What is atlanto-occipital assimilation? Atlanto-occipital assimilation is a failure of segmentation between the occiput and atlas that results in partial or complete bony fusion. This reduces the mobility of the atlanto-occipital joint and redistributes stress to the atlantoaxial joint, predisposing the patient to atlantoaxial instability. It frequently coexists with basilar invagination, Chiari I malformation, and vertebral artery anatomical variants. Patients develop headache, restricted neck motion, and progressive myelopathic symptoms if the canal diameter is reduced. Q. What is basilar invagination and how is it classified? Basilar invagination is the upward migration of the odontoid process into the foramen magnum, causing ventral compression of the medulla. It is most commonly congenital but may also be secondary to bone softening disorders. The odontoid lies above Chamberlain’s line or McGregor’s line and may project above the foramen magnum itself. Congenital basilar invagination is associated with assimilation of the atlas, platybasia, and often Chiari I malformation. Q. What is platybasia? Platybasia is an abnormal flattening of the skull base caused by dysgenesis of the clivus. It often coexists with basilar invagination and is recognized by an abnormally increased basal angle. Its significance lies in its association with ventral brainstem compression when combined with upward migration of the odontoid. Q. What is odontoid hypoplasia or aplasia? Odontoid hypoplasia refers to a short, underdeveloped dens, while aplasia refers to complete absence of the dens. These abnormalities impair the pivot function of the odontoid and predispose to gross atlantoaxial instability. They are common in skeletal dysplasias such as Morquio disease and in Down syndrome. Clinical manifestations include myelopathy, respiratory compromise, and episodes of transient quadriplegia. Q. What are congenital C1 arch defects? C1 arch defects arise from incomplete chondrification of the neural arches of the atlas. Posterior arch clefts or complete absence of the posterior arch may occur, and these can be misinterpreted as fractures if unrecognized. Although usually asymptomatic, some patients may develop myelopathy from posterior arch inward buckling or from associated instability. The vertebral artery may course anomalously through the defect, which is important during surgical instrumentation. Q. How do Chiari I malformation and CVJ anomalies relate? Chiari I malformation frequently coexists with basilar invagination, retroflexed odontoid, clival hypoplasia, and atlas assimilation. Reduced posterior fossa volume or ventral brainstem compression impairs CSF flow at the foramen magnum, resulting in tonsillar herniation and sometimes syringomyelia. In these patients, posterior fossa decompression may be insufficient if a significant ventral compressive component persists, necessitating atlantoaxial realignment or ventral decompression depending on reducibility. Q. What clinical features suggest congenital CVJ anomalies? Patients present with suboccipital or upper cervical pain, restricted neck movements, gait imbalance, long tract signs, hand clumsiness, spasticity, lower cranial nerve dysfunction, and in severe ventral compression, respiratory or swallowing difficulty. Drop attacks, syncope, or visual obscurations suggest vertebral artery compromise. Children may exhibit torticollis, developmental delay, or recurrent falls. Exacerbation of symptoms with flexion or extension suggests instability. Q. What imaging studies are required to evaluate these anomalies? Dynamic flexion and extension radiographs assess atlantoaxial instability. CT with sagittal and coronal reconstructions delineates bony anatomy, odontoid morphology, assimilation, platybasia, and the course of the vertebral arteries. MRI identifies cervicomedullary compression, tonsillar herniation, cord signal changes, and syringomyelia. Important measurements include the position of the odontoid relative to Chamberlain’s, McGregor’s, and McRae’s lines, the clivus-canal angle, and evaluation of reducibility on traction imaging. These measurements guide surgical planning, especially when choosing between posterior fusion and ventral decompression. Q. How do you manage congenital atlantoaxial instability? Management depends on symptoms and imaging findings. Symptomatic or radiographically significant instability requires surgical stabilization. Posterior C1–C2 fusion with instrumentation is the preferred approach. Distraction techniques may be used to realign the odontoid in reducible basilar invagination. Occipitocervical fusion is reserved for cases with atlanto-occipital assimilation, comminuted anomalies that preclude C1 fixation, or when alignment cannot be achieved at C1–C2 alone. Below is a concise list. A. C1–C2 Fusion Indications: AAI Os odontoideum Odontoid hypoplasia Reducible basilar invagination (Goel type A) Goel emphasizes C1–C2 distraction and fusion for reducible BI. B. Occipitocervical Fusion Indications: Irreducible AAI Occipital assimilation with instability Non-reducible BI Combined malformations affecting both OC–C1 and C1–C2 stability C. Ventral decompression (Transoral / Endoscopic endonasal odontoidectomy) Indications - Irreducible ventral compression by: Retroflexed dens Basilar invagination Severe platybasia Often followed by occipitocervical fusion. Q. When is ventral decompression indicated? Ventral decompression is indicated when irreducible ventral compression persists after maximal extension or traction. The common causes include a retroflexed odontoid, fixed basilar invagination, or severe platybasia. Transoral or endoscopic endonasal odontoidectomy is used to resect the offending dens, but posterior occipitocervical fusion is usually required afterward to maintain stability. Q. How are associated Chiari malformations addressed in the presence of CVJ anomalies? If ventral compression is significant, realignment or ventral decompression is performed first. Posterior fossa decompression is added when tonsillar herniation or syringomyelia persists after correction of the ventral pathology. In some cases of reducible basilar invagination, atlantoaxial distraction alone restores the CSF channels sufficiently to improve Chiari physiology without requiring posterior fossa decompression. Q. What complications may arise if congenital CVJ anomalies are untreated? Progressive cervicomedullary compression results in spastic quadriparesis, respiratory compromise, acute neurological deterioration from minor trauma, vertebral artery insufficiency, and sudden death. Chronic compression causes cord signal change, cranial nerve dysfunction, and irreversible neurological deficits. Instability may worsen with age, and minor neck movements may precipitate catastrophic neurological decline. Q. What factors determine prognosis after surgical correction of congenital CVJ anomalies? Prognosis depends on the degree and chronicity of medullary or spinal cord compression, the presence of syringomyelia, patient age, and the adequacy of decompression and stabilization. Early surgical intervention yields the best neurological recovery. Long-standing cord signal changes and severe ventral compression predict incomplete recovery. Proper alignment and robust fixation provide excellent long-term outcomes with low recurrence of symptoms.